Description
The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across various innovations. The TOE describes disruptive technological developments across stem cell platforms, personalized medicine, use of artificial intelligence for Alzheimer’s disease, gene therapies, melanoma management, biomarkers, vaccines, liver cancer management, monoclonal antibodies, and the management of post-partum depression.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Stem cells, personalized medicine, biomarkers, artificial intelligence, gene therapy, monoclonal antibody, melanoma, Alzheimer’s disease, liver cancer, post-partum depression
Don't have an account? Create One!
Already have an account? Login!
Connect With LinkedIn
Use your Linkedin account to login or register within our store.You're just one click away.